Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SOHO 2022 | The biology of Ph-like ALL and challenges in this disease subtype

Emily Curran • 28 Sep 2022
SOHO 2022
Acute Lymphoblastic Leukemia Leukemia

Emily Curran, MD, The University of Cincinnati, Cincinnati, OH, gives an overview of the biology of Ph-like acute lymphoblastic leukemia (ALL), and further highlights challenges with treating this patient population. This interview took place at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO) held in Houston, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Emily Curran

1:20
The evolving role of inotuzumab ozogamicin in the treatment of pediatric & older patients with ALL
Emily Curran • 28 Sep 2022
1:31
How the treatment and management of ALL changes with age
Emily Curran • 28 Sep 2022
2:04
Treatment approaches to Ph-like ALL: challenges and future outlooks
Emily Curran • 28 Sep 2022

Related Videos

2:06
Managing relapsed ALL: the role of novel cellular therapies & importance of conditioning regimens
Christina Peters • 15 Apr 2024
1:14
Promising novel agents in AML: menin inhibitors
Mark Levis • 16 Apr 2024
3:02
EUPLAGIA-1: Phase I trial of GLPG5201, a CD19 CAR-T product, in R/R CLL and Richter's transformation
Valentin Ortiz-Maldonado • 16 Apr 2024
1:48
Do all patients require maintenance therapy following alloSCT?
Mark Levis • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals